On May 9, the Engelberg Center for Health Care Reform convened an expert workshop “Innovative Technologies and Nonprescription Medications: Addressing Undertreated Diseases and Conditions through Technology Enabled Self-Care.”
Recognizing the public health impact of undertreatment of common diseases and conditions, the U.S. Food and Drug Administration is exploring how a regulatory expansion of the nonprescription drug class might increase access to important medications and treatments. This initiative is referred to as Nonprescription Safe Use Regulatory Expansion (NSURE).
At this meeting, a wide range of experts and stakeholders explored the use of technologies as a condition to the safe use of medications within a nonprescription setting, discussed perspectives on the role of technology to support the safe and effective use of nonprescription products, and explored the integration of innovative technologies into the health care delivery system.
This expert workshop was the second in a series of meetings that will explore the NSURE initiative. To explore previous discussion regarding the potential role of health care professionals as a condition of safe use within the NSURE paradigm, please visit our expert workshop, “Nonprescription Medications with Conditions of Safe Use as a Novel Solution for Undertreated Diseases or Conditions”
Vice President, Regulatory Affairs, Wellness Category and North America - GlaxoSmithKline Consumer Healthcare
Director, Regulatory Affairs - GlaxoSmithKline Consumer Healthcare
Chief Executive Officer - Central Control, Inc.
Chief Strategy Officer - Rock Health
Vice President - Farmacia Electronica, Inc.
Vice President - Global R&D, Rx-to-OTC Switch and New Opportunity Evaluation, Merck Consumer Care
Senior Vice President, Global R&D and Switch - Pfizer Consumer Healthcare
Director, Health Ratings Center - Consumer Health Choices
Associate Vice President, Practice and Science Affairs - American Pharmacists Association
Executive Director - Pharmacy e-Health Information Technology Collaborative
Chief Executive Officer - PDR Network
National Director, Pharmacy Affairs - Walgreens
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.